Immunization with modified vaccinia virus Ankara prevents eczema vaccinatum in a murine model of atopic dermatitis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 21820712.
- Also identified by DOI 10.1016/j.jaci.2011.06.042 and PMC identifier 3185136.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Immunization with modified vaccinia virus Ankara (MVA) protects mice with allergic skin inflammation from developing eczema vaccinatum (EV), suggesting that immunization with MVA would be effective in preventing EV in patients with atopic dermatitis.
Medical subject headings
- Dermatitis, Atopic
- Kaposi Varicelliform Eruption
- Smallpox Vaccine
- Vaccinia virus